Published in Respirology on November 01, 2011
Biomarkers of progression of chronic obstructive pulmonary disease (COPD). J Thorac Dis (2014) 1.14
Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res (2012) 1.08
Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath. Metabolites (2015) 1.03
Application of the electronic nose technique to differentiation between model mixtures with COPD markers. Sensors (Basel) (2013) 0.93
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. Metabolites (2015) 0.87
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease. PLoS One (2015) 0.78
Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. World J Gastroenterol (2016) 0.76
Electronic Nose Technology in Respiratory Diseases. Lung (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.82
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J (2013) 2.87
Indoor air contamination during a waterpipe (narghile) smoking session. Food Chem Toxicol (2009) 2.48
Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest (2007) 2.36
Whole-Body Plethysmography in Suspected Asthma: A Prospective Study of Its Added Diagnostic Value in 302 Patients. Dtsch Arztebl Int (2015) 2.34
Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg (2008) 1.91
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest (2006) 1.84
Detection of obstructive sleep apnoea by an electronic nose. Eur Respir J (2012) 1.66
The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res (2011) 1.65
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun (2002) 1.57
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol (2005) 1.57
Antimicrobial peptides: current status and therapeutic potential. Drugs (2003) 1.55
Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol (2007) 1.53
Superior vena cava syndrome in thoracic malignancies. Respir Care (2011) 1.52
Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS One (2011) 1.45
E-cigarettes--prevention, pulmonary health, and addiction. Dtsch Arztebl Int (2014) 1.43
Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med (2002) 1.38
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer (2007) 1.36
Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults? Chest (2002) 1.34
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers (2005) 1.32
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res (2010) 1.31
Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol (2006) 1.31
The discovery of α1-antitrypsin and its role in health and disease. Respir Med (2011) 1.30
Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros (2004) 1.29
Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS One (2008) 1.22
Peripheral arterial tonometry, oximetry and actigraphy for ambulatory recording of sleep apnea. Physiol Meas (2004) 1.22
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax (2013) 1.20
Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ (2012) 1.20
Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J Leukoc Biol (2007) 1.18
Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol (2004) 1.18
Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med (2008) 1.14
The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol (2006) 1.13
The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol (2010) 1.12
The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides (2006) 1.12
Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial. Chest (2013) 1.09
Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol (2010) 1.08
MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia. Cell Cycle (2010) 1.07
Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD. COPD (2010) 1.06
Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection. J Virol (2008) 1.06
Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function. Am J Respir Crit Care Med (2004) 1.05
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J Chron Obstruct Pulmon Dis (2012) 1.04
Antimicrobial peptides in lung inflammation. Chem Immunol Allergy (2005) 1.04
Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J (2013) 1.04
Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci (2005) 1.04
FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells. J Immunol (2013) 1.03
Chronic obstructive pulmonary disease and premature aging. Am J Respir Crit Care Med (2007) 1.02
Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.02
Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med (2009) 1.02
Dynamics of heart rate and sleep stages in normals and patients with sleep apnea. Neuropsychopharmacology (2003) 1.02
Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration (2004) 1.00
Nonrandom variability of respiration during sleep in healthy humans. Sleep (2005) 1.00
Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing. PLoS One (2013) 1.00
Development of a 1-concentration-4-step dosimeter protocol for methacholine testing. Respir Med (2008) 0.97
FENO measurement and sputum analysis for diagnosing asthma in clinical practice. Respir Med (2012) 0.97
The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease. Int J Cardiol (2010) 0.97
Direct medical costs of COPD--an excess cost approach based on two population-based studies. Respir Med (2011) 0.95
Intervention by phone calls raises domiciliary activity and exercise capacity in patients with severe COPD. Respir Med (2007) 0.95
The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther (2007) 0.95
Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res (2009) 0.94
Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. J Clin Pharmacol (2005) 0.94
Whole-body vibration therapy in intensive care patients: A feasibility and safety study. J Rehabil Med (2016) 0.94
Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med (2007) 0.93
Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD (2011) 0.93
Proteinase-mediated release of epithelial cell-associated CD44. Extracellular CD44 complexes with components of cellular matrices. J Biol Chem (2002) 0.92
Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled study. BMC Pulm Med (2014) 0.91
Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis. Respiration (2015) 0.91
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. Respir Res (2009) 0.91
Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med (2008) 0.91
IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signaling. Int Arch Allergy Immunol (2006) 0.90
Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care (2012) 0.89
Series introduction: Innate host defense of the respiratory epithelium. J Leukoc Biol (2003) 0.89
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infect Dis (2012) 0.89
Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients. Respir Med (2011) 0.88
Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration (2009) 0.88